MENU
+Compare
BMED
ETF ticker: NYSE ARCA
AS OF
Jun 27 closing price
Price
$24.71
Change
+$0.04 (+0.16%)
Net Assets
3.95M

BMED stock forecast, quote, news & analysis

The investment seeks to maximize total return... Show more

Category: #Health
BMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BMED with price predictions
Jun 27, 2025

BMED's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for BMED moved out of overbought territory on June 13, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on June 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMED as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BMED broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BMED just turned positive on June 26, 2025. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

BMED moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BMED crossed bullishly above the 50-day moving average on May 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 253 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX).

Industry description

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Market Cap

The average market capitalization across the iShares Health Innovation Active ETF ETF is 34.22B. The market cap for tickers in the group ranges from 79.23M to 380.22B. JNJ holds the highest valuation in this group at 380.22B. The lowest valued company is TCRX at 79.23M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 2%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was -2%. AUTL experienced the highest price growth at 12%, while EWTX experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 32%. For the same stocks of the ETF, the average monthly volume growth was 109% and the average quarterly volume growth was 293%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 75
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 80
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
BMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
BlackRock ETF Trust100 BELLEVUE PARKWAY
Phone
N/A
Web
www.blackrock.com